Trump Administration Links Tylenol Use During Pregnancy to Autism Risk
President Trump announced that the FDA advises limiting Tylenol use during pregnancy due to a potential autism risk, a claim disputed by medical experts and the drug's manufacturer.
President Donald Trump announced on Monday that the Food and Drug Administration (FDA) is advising physicians to recommend that pregnant women limit the use of acetaminophen, commonly known as Tylenol, unless medically necessary, due to a potential association with an increased risk of autism.
Medical experts and the drug's manufacturer have contested this claim. The American College of Obstetricians and Gynecologists (ACOG) stated that there is no clear evidence proving a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues. Kenvue, the maker of Tylenol, emphasized that independent, sound science clearly shows that taking acetaminophen does not cause autism.
The administration also announced the initiation of an approval process for leucovorin, a drug typically used in cancer treatment, as a potential treatment for autism symptoms, despite limited evidence of its efficacy in this context.
During the press conference, Trump and Health and Human Services Secretary Robert F. Kennedy Jr. suggested that the childhood vaccine schedule could contribute to autism, contradicting years of research that has found no link between the two.